Pacifico Biolabs
Develops mycelium fermentation processes to produce alternative protein, scaling production in disused brewery tanks across Europe.
Overview
Pacifico Biolabs is building a mycelium fermentation platform for alternative protein, positioning itself as a rival to Quorn. The company is focused on scaling production in Europe by using disused brewery tanks as fermentation infrastructure. The approach targets the alternative-protein market with a differentiated manufacturing strategy that repurposes existing brewing assets. Pacifico Biolabs raised a €7M Series A in May 2026 to support its European scale-up.
Funding History
Quorn rival Pacifico Biolabs raises €7M Series A to scale mycelium fermentation in Europe’s disused brewery tanks
Frequently Asked Questions
- How much funding does AI Funding track for Pacifico Biolabs?
- AI Funding tracks €7M for Pacifico Biolabs across 1 funding round in this database.
- Who are Pacifico Biolabs's investors?
- Pacifico Biolabs's investors include Stray Dog Capital.
- What does Pacifico Biolabs do?
- Pacifico Biolabs is building a mycelium fermentation platform for alternative protein, positioning itself as a rival to Quorn. The company is focused on scaling production in Europe by using disused brewery tanks as fermentation infrastructure. The approach targets the alternative-protein market with a differentiated manufacturing strategy that repurposes existing brewing assets. Pacifico Biolabs raised a €7M Series A in May 2026 to support its European scale-up.
- Where is Pacifico Biolabs headquartered?
- Pacifico Biolabs is headquartered in Europe.
Investors
Related Insights
Compare the leading AI-focused VC firms: Andreessen Horowitz, Sequoia Capital, Thrive Capital, and 7 more. Analysis of 150+ AI deals, investment strategies, sector focus, and portfolio performance.
Track 395+ AI funding rounds—investors, valuations, and deal sizes from pre-seed to IPO. Updated daily so you never miss a round.
An in-depth look at how AI-focused venture capital operates — from fund structure and deal sourcing to due diligence, portfolio management, and exit strategies in the AI era.